Treatment for Suicide

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Xavier University Psychological Services Clinic, Cincinnati, OH
Suicide+3 More
Clairity - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This is a clinical trial to evaluate the effectiveness of the Clairity tool within the university setting for students who are being seen by a mental health provider.

Eligible Conditions

  • Anxiety
  • Mental Health Issue
  • Suicide
  • Depression

Treatment Effectiveness

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 12 month

12 month
Clairity Dashboard
Clinical Utility Treatment Outcomes
Identify Mental States with Area Under the AUC metric
Outcome Measure Comparison

Trial Safety

Trial Design

2 Treatment Groups

Control
1 of 2
Treatment
1 of 2
Active Control
Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Treatment · No Placebo Group · N/A

Treatment
Behavioral
Experimental Group · 1 Intervention: Clairity · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 month
Closest Location: Xavier University Psychological Services Clinic · Cincinnati, OH
Photo of Cincinnati  1Photo of Cincinnati  2Photo of Cincinnati  3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Suicide
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.